Screener
Perspective Therapeutics CATX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342512
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Deferred Income1 | - | (1,400) |
| Accrued personnel expenses | (1,517) | (441) |
| Other noncurrent liabilities | 121 | 229 |
| Net cash used in operating activities | (52,118) | (41,535) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Additions to property and equipment | (21,053) | (5,682) |
| Additions to other assets | (21) | (45) |
| Purchases of available-for-sale securities | (185,952) | (67,094) |
ITEM 1 - FINANCIAL STATEMENTS
FAQ
- What is Perspective Therapeutics's operating cash flow?
- Perspective Therapeutics (CATX) reported operating cash flow of -$20.65M in Q2 2026.
- How has Perspective Therapeutics's operating cash flow changed year-over-year?
- Perspective Therapeutics's operating cash flow decreased by 3.5% year-over-year, from -$19.95M to -$20.65M.
- What is the long-term trend for Perspective Therapeutics's operating cash flow?
- Over 3 years (2022 to 2025), Perspective Therapeutics's operating cash flow has grown at a 99.4% compound annual growth rate (CAGR), from -$10.4M to -$82.48M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Perspective Therapeutics's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude